Warrants (Details) - $ / shares |
1 Months Ended | 6 Months Ended |
|---|---|---|
Apr. 19, 2022 |
Jul. 31, 2022 |
|
| Warrants (Details) | ||
| Warrants Outstanding Shares, Beginning | 4,991,000 | |
| Exercised, Shares | (125,000) | |
| Granted, Shares | 25,000 | |
| Exercised | (500,000) | (535,000) |
| Warrants Outstanding Shares, Ending | 4,356,000 | |
| Warrants Outstanding Weighted Average Conversion Price, Beginning | $ 2.83 | |
| Weighted Average Conversion Price, Exercised | 1.00 | |
| Weighted Average Conversion Price, Granted | 9.00 | |
| Warrants Outstanding Weighted Average Conversion Price, Ending | 3.00 | |
| Weighted Average Conversion Price, Exercise | $ 6.00 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Change in the weighted average exercise price of options outstanding. No definition available.
|
| X | ||||||||||
- Definition Number of share options (or share units) exercised during the current period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Per share increase in exercise price of warrant. Excludes change due to standard antidilution provision. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|